Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel

2011101 citationsJournal Articlegold Open Access

Authors

Bomback · Columbia University

James A. Tumlin · University of Tennessee at Chattanooga

Joel Baranski · Balboa Nephrology Medical Group

J. E. Bourdeau · Oklahoma Cancer Specialists and Research Institute

Anatole Besarab · Henry Ford Health System

Alice Sue Appel · Columbia University

Radhakrishnan

Abstract

ACTH gel may be a viable treatment option for resistant nephrotic syndrome due to membranous nephropathy. Short-term data suggest that remission rates may approach 80%.

Topics & Keywords

Renal Diseases and Glomerulopathies Autoimmune Bullous Skin Diseases Platelet Disorders and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Drug Design Development and Therapy

Volume 5, pp. 147-147

DOI: 10.2147/dddt.s17521

Field-Weighted Citation Impact: 5.21